GC40667
Aurora Kinase Inhibitor II
Also known as N-[4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenyl]benzamide
Aurora Kinase Inhibitor II is a selective and ATP-competitive Aurora kinase inhibitor with IC50s of 310 nM and 240 nM for Aurora A and Aurora B, respectively
ChemicalCAS331770-21-9MW400.4FormulaC23H20N4O3
- CAS number
- 331770-21-9
- Molecular weight
- 400.4
- Formula
- C23H20N4O3
- Solubility
- DMF： 0·25 mg/ml,DMF：PBS(pH7·2) (1：2)： 0·33 mg/ml,DMSO： 2·5 mg/ml
- InChIKey
- IMYVCWQAHSYYOO-UHFFFAOYSA-N
- Catalogue number
- GC40667
- Brand
- GLPBIO
Computed properties PubChem CID 6610278 · XLogP 4.2 · TPSA 85.4 Ų · H-bond donors 2
- XLogP
- 4.2
- TPSA
- 85.4 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 6
- Heavy atoms
- 30
SMILES COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OC
Computed descriptors from PubChem (CID 6610278), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il